Amundi Asset Management US’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $3.94M | Buy |
52,928
+12,027
| +29% | +$896K | ﹤0.01% | 1067 |
|
|
2020
Q4 | $6.97M | Buy |
40,901
+9,401
| +30% | +$1.6M | 0.01% | 886 |
|
|
2020
Q3 | $4.42M | Sell |
31,500
-163,495
| -84% | -$23M | ﹤0.01% | 922 |
|
|
2020
Q2 | $31.3M | Buy |
194,995
+18,131
| +10% | +$2.91M | 0.04% | 414 |
|
|
2020
Q1 | $17.3M | Buy |
176,864
+3,935
| +2% | +$385K | 0.03% | 431 |
|
|
2019
Q4 | $22.3M | Buy |
172,929
+1,816
| +1% | +$234K | 0.03% | 525 |
|
|
2019
Q3 | $12.9M | Sell |
171,113
-23,732
| -12% | -$1.79M | 0.02% | 637 |
|
|
2019
Q2 | $29.6M | Buy |
194,845
+40,234
| +26% | +$6.11M | 0.02% | 469 |
|
|
2019
Q1 | $18.4M | Buy |
154,611
+38,194
| +33% | +$4.55M | 0.03% | 540 |
|
|
2018
Q4 | $12.7K | Sell |
116,417
-295
| -0.3% | -$32 | 0.01% | 583 |
|
|
2018
Q3 | $18.9M | Buy |
116,712
+13,294
| +13% | +$2.15M | 0.02% | 552 |
|
|
2018
Q2 | $13.7M | Buy |
103,418
+53,756
| +108% | +$7.11M | 0.02% | 633 |
|
|
2018
Q1 | $3.68M | Buy |
+49,662
| New | +$3.68M | 0.01% | 929 |
|